Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginInterest Coverage RatioNet MarginOperating MarginReturn on SalesTimes Interest Earned

Solid Biosciences (SLDB) Operating Margin (2021 - 2024)

Solid Biosciences (SLDB) has disclosed Operating Margin for 4 consecutive years, with 53194.67% as the latest value for Q4 2024.

  • Quarterly Operating Margin changed N/A to 53194.67% in Q4 2024 from the year-ago period, while the trailing twelve-month figure was 38155.29% through Dec 2024, down 4800338.0% year-over-year, with the annual reading at 88278.82% for FY2025, 12643411.0% down from the prior year.
  • Operating Margin hit 53194.67% in Q4 2024 for Solid Biosciences, up from 42904.88% in the prior quarter.
  • In the past five years, Operating Margin ranged from a high of 53194.67% in Q4 2024 to a low of 1318.03% in Q1 2022.
  • Historically, Operating Margin has averaged 17915.82% across 4 years, with a median of 13029.82% in 2022.
  • Biggest five-year swings in Operating Margin: plummeted -81170bps in 2022 and later surged 2778910bps in 2023.
  • Year by year, Operating Margin stood at 509.78% in 2021, then rose by 19bps to 411.44% in 2022, then skyrocketed by 6534bps to 26471.07% in 2023, then surged by 101bps to 53194.67% in 2024.
  • Business Quant data shows Operating Margin for SLDB at 53194.67% in Q4 2024, 42904.88% in Q3 2024, and 31577.27% in Q2 2024.